Abstract:Background Incidental extrapulmonary findings are commonly detected on chest CT scans and can be clinically important. Purpose To integrate artificial intelligence (AI)-based segmentation for multiple structures, coronary artery calcium (CAC), and epicardial adipose tissue with automated feature extraction methods and machine learning to detect extrapulmonary abnormalities and predict all-cause mortality (ACM) in a large multicenter cohort. Materials and Methods In this post hoc analysis, baseline chest CT scans in patients enrolled in the National Lung Screening Trial (NLST) from August 2002 to September 2007 were included from 33 participating sites. Per scan, 32 structures were segmented with a multistructure model. For each structure, 15 clinically interpretable radiomic features were quantified. Four general codes describing abnormalities reported by NLST radiologists were applied to identify extrapulmonary significant incidental findings on the CT scans. Death at 2-year and 10-year follow-up and the presence of extrapulmonary significant incidental findings were predicted with ensemble AI models, and individualized structure risk scores were evaluated. Area under the receiver operating characteristic curve (AUC) analysis was used to evaluate the performance of the models for prediction of ACM and extrapulmonary significant incidental findings. The Pearson χ2 test and Kruskal-Wallis rank sum test were used for statistical analyses. Results A total of 24 401 participants (median age, 61 years [IQR, 57-65 years]; 14 468 male) were included. In 3880 of 24 401 participants (16%), 4283 extrapulmonary significant incidental findings were reported. During the 10-year follow-up, 3389 of 24 401 participants (14%) died. CAC had the highest feature importance for predicting the three study end points. The 10-year ACM model demonstrated the best AUC performance (0.72; per-year mortality of 2.6% above and 0.8% below the risk threshold), followed by 2-year ACM (0.71; per-year mortality of 1.13% above and 0.3% below the risk threshold) and prediction of extrapulmonary significant incidental findings (0.70; probability of occurrence of 25.4% above and 9.6% below the threshold). Conclusion A fully automated AI model indicated extrapulmonary structures at risk on chest CT scans and predicted ACM with explanations. ClinicalTrials.gov Identifier: NCT00047385 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Yanagawa and Hata in this issue.

AI Body Composition in Lung Cancer Screening: Added Value Beyond Lung Cancer Detection

Body composition as a biomarker for assessing future lung cancer risk

The added value of an AI-based body composition analysis in a lung cancer screening population: preliminary results

Automated detection of lung nodules and coronary artery calcium using artificial intelligence on low-dose CT scans for lung cancer screening: accuracy and prognostic value

AI for Multistructure Incidental Findings and Mortality Prediction at Chest CT in Lung Cancer Screening.

AI-based volumetric six-tissue body composition quantification from CT cardiac attenuation scans enhances mortality prediction: multicenter study

Application of artificial intelligence in lung cancer screening: A real-world study in a Chinese physical examination population

AI in Lung Health: Benchmarking Detection and Diagnostic Models Across Multiple CT Scan Datasets

A Classifier for Improving Early Lung Cancer Diagnosis Incorporating Artificial Intelligence and Liquid Biopsy

Computed Tomography–based Body Composition Analysis and Its Role in Lung Cancer Care

Body Composition Assessment with Limited Field-of-view Computed Tomography: A Semantic Image Extension Perspective

Role of Machine Learning-Based CT Body Composition in Risk Prediction and Prognostication: Current State and Future Directions

The value of artificial intelligence in the diagnosis of lung cancer: A systematic review and meta-analysis

AI-Driven Models for Diagnosing and Predicting Outcomes in Lung Cancer: A Systematic Review and Meta-Analysis

Artificial intelligence in lung cancer screening: Detection, classification, prediction, and prognosis

Artificial intelligence predicts lung cancer radiotherapy response: A meta-analysis

Application analysis of ai technology combined with spiral CT scanning in early lung cancer screening

Artificial Intelligence Assisted Computational Tomographic Detection of Lung Nodules for Prognostic Cancer Examination: A Large-Scale Clinical Trial

Artificial Intelligence and Lung Cancer: Impact on Improving Patient Outcomes

Artificial intelligence-aided CT segmentation for body composition analysis: a validation study

Artificial Intelligence in Lung Cancer Screening: The Future Is Now